Company intelligence / Profile preview

Allozymes

Singapore, -, Singaporeallozymes.com ↗
Ownership
Private
Employees
~50
Development stage
Commercial
01

Overview

Allozymes has developed a proprietary microfluidics-based platform that enables ultra-high-throughput screening and engineering of enzymes. The company partners with organizations across pharmaceuticals, life sciences & diagnostics, food & nutrition, chemicals, bioremediation/environmental cleanup, personal care/cosmetics—delivering custom biosolutions that are more sustainable than traditional methods. Recent partnerships include Adisseo for next-generation animal feed ingredient production using engineered enzymes for methionine synthesis. The company has raised over $20M in funding and continues expanding globally with new subsidiaries in Europe.

Therapeutic areas
Metabolic Disorders
Modalities
Enzymes (custom-designed/engineered enzymes for various applications)Small molecules (via enzyme-enabled synthesis in pharma)Bioprocessing solutions
Industry
Non-Drug Biotech
02

Partnerships

Adisseo (animal nutrition/methionine)Bonumose (food/supplement ingredients)

Beyond the preview

Go deeper on Allozymes.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allozymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call